FR2860158A1 - Foaming, cleaning composition containing a polyguanidine derivative, useful as cosmetic cleanser and for treating greasy skin, also contains at least one lathering surfactant - Google Patents

Abstract

Foaming, cleaning composition (A) comprises, in a physiologically acceptable aqueous medium, at least one polyguanidine derivative (I) and at least one foaming surfactant (II), where (II) is more than 5wt.% of the total composition.

Description

<Desc / Clms Page number 1>

 The present invention relates to a rinse-off foaming cleaning composition comprising a polyguanidine derivative, and to the use of said composition, in particular in the cosmetic or dermatological field, as products of a polyvinylidine derivative. cleaning or removing makeup from the skin, eyes, scalp and / or hair and / or as products for treating human skin.

The cleaning of the skin is very important for the care of the face. It must be as efficient as possible because fatty residues such as excess sebum, the remains of cosmetics used daily and makeup products accumulate in skin folds and can clog the pores of the skin and lead to appearance of buttons.

One way to clean the skin properly is to use foaming cleansers. Foaming cleansers currently available commercially are in the form of loaves, gels or foaming creams, and may or may not contain soaps (fatty acid salts). Foaming products with soap have the advantage of giving a creamy foam; however, some consumers blame these products for causing tension due to their excessive detergency. In order to have a better tolerated product, it is desired to reduce the level of soaps or even to eliminate them from foaming cleaning compositions.

In addition, foaming products without soap are generally well tolerated.

However, the foam qualities are worse than those obtained with the products that contain soaps, especially the foams generated are coarse and rough. One way to improve the qualities of foam and to obtain qualities close to those of products with soap (soft foam, dense, with small bubbles) is to introduce cationic polymers.

However, the cationic polymers have the disadvantage of leaving a film on the skin, which results in a so-called film-forming or sliding rinse. This type of rinse is not appreciated by consumers because it gives the impression of poorly washed skin. In addition, cationic polymers adversely affect the volume of the foam.

Thus, there remains the need for rinsable foaming products, which even without soap, have the properties required for foaming products, namely good qualities of the foam obtained and good comfort of use (softness).

The Applicant has discovered, surprisingly, that the introduction of a polyguanidine derivative into the foaming compositions made it possible to obtain an abundant, dense and soft foam.

Thus, the compositions according to the invention give a more dense and voluminous foam than compositions which do not contain the polyguanidine derivative, as shown in the comparative examples below.

<Desc / Clms Page number 2>

Thus, the present application relates to a foaming cleaning composition comprising, in a physiologically acceptable aqueous medium, at least one polyguanidine derivative and one or more foaming surfactants, these surfactants being in an amount greater than 5% by weight relative to total weight of the composition.

The term "physiologically acceptable medium" means a medium that is compatible with the skin, the mucous membranes, the scalp, the eyes and / or the hair. Furthermore, it is an aqueous medium, that is to say a medium comprising water and preferably a quantity of water of at least 35% by weight, for example ranging from 35 to 95% by weight and better still 40 to 80% by weight relative to the total weight of the composition.

The compositions of the invention are foaming and rinsable cleaning compositions, suitable for topical application, and especially for application to the skin. They are in the form of a gel which may or may not flow under its own weight, that is to say having a viscosity ranging for example from 5 poises to 250 poises (0.5 to 25 Pa · s). and preferably of 35 poises at 200 poise (3.5 to 20 Pa.s), the viscosity being measured at 25 C with a Rheomat 180 to 200 s-1, this apparatus being equipped with a different mobile depending viscosities, for example of a mobile 2 for ranges of viscosities less than 7 poises, a mobile 3 for the viscosity ranges of 2 to 40 poise, and a mobile 4 for the viscosity ranges greater than 20 poise.

The polyguanidine derivatives are known as anti-bacterial agents in disinfecting solutions, as described for example in US-A-2002/0122821 and US-A-6,465,412, or as fiber protection agents. in products for treating keratin fibers, as described in EP-A-1,302,194. There was no suggestion that these derivatives would be effective in increasing the foam quality of the foaming cleansing compositions.

Also, the subject of the present invention is also the use of at least one polyguanidine derivative, for improving the quality of foam, and in particular the foam volume and the foam density, of a rinsing foaming cleaning composition comprising, in a physiologically acceptable aqueous medium, one or more foaming surfactants in an amount greater than 5% by weight relative to the total weight of the composition.

The polyguanidine derivatives which may be used in the context of the present invention are in particular compounds of the following formula (I):

<Desc / Clms Page number 3>

in which :
X, R1, R2, R3, independently of one another, are chosen from the group formed by a hydrogen atom, a hydroxyl radical, a C1-C16 alkyl radical, preferably a C1-C8 linear alkyl radical; or branched, saturated or unsaturated, hydroxylated or not,
Y denotes an NHR radical, in which R is chosen from the group formed by a hydrogen atom, a hydroxyl radical, a C1-C16, preferably C1-C8, linear or branched, saturated or unsaturated, hydroxyl-substituted alkyl radical; or not,
A denotes a linear or branched, saturated or unsaturated C 1 -C 16, preferably C 1 -C 12, alkylene radical, optionally substituted by at least one radical chosen from a hydroxyl radical, carboxyl (-COOH), carboxylate, a halogen, said alkylene radical may contain at least one amine (-NH-), ether (-O-), thioether (-S-), ester (- (CO) O- or -O (CO) -), amide (- CONR- or -NRCO- where R is hydrogen, a C1-C8 alkyl radical, carbamate (-NH (CO) O- or O (CO) NH-), urea (-NH (CO) NH-), a C 6 -C 8 aryl or C 3 -C 8 cyclanic ring optionally substituted with C 1 -C 6 alkyl, hydroxyl, halogen; or A denotes one or more C5 to C7 aranic or C5 to C7 cyclanic rings optionally substituted with C1-C6 alkyl, hydroxyl or halogen or unsubstituted; or A denotes a C10-C14 polyaryl chain or a C6-C10 polycyclic chain which may be interrupted by at least one C1-C8 alkylene radical, a hydrogen atom, an amine (-NH-) amide function (- CONR- or NRCO where R is a C1-C6 alkyl radical, ether (-O-), thioether (-S-), carbamate (-NH (CO) O- or -O (CO) NH-), urea (-NH (CO) NH-); n is an integer from 2 to 5000, and preferably from 2 to 200, and their physiologically acceptable salts.

For the purposes of the present application, the term "carboxylate" means a carboxylic acid addition salt with a base chosen in particular from soda, potassium hydroxide, ammonia, amines or alkanolamines or an internal salt. ampholyte with a guanidinium group of the chain.

For the purposes of the present patent application, the term "C6 aryl ring" means a benzene ring, which ring may be substituted by one or two C 1 -C 8 alkyl, hydroxyl or halogen radicals.

For the purposes of the present patent application, the term "C10-C14 polyaryl chain" means a chain containing 2 or 3 aromatic rings, each optionally substituted with one or two C 1 -C 8 alkyl, hydroxyl or halogen radicals.

Preferably, it is more particularly the derivatives of formula (1) defined above, in which A denotes a linear or branched, saturated or unsaturated C 1 -C 6 alkylene radical substituted or unsubstituted by at least one radical chosen from hydroxyl, carboxyl, carboxylate or halogen radicals (fluorine, chlorine, bromine, iodine).

As polyguanidine derivatives, homopolymers as well as heteropolymers can be used.

<Desc / Clms Page number 4>

For the purposes of the present patent application, the term "homopolymer" is intended to mean a polymeric chain consisting of (-N (R 1) -C (NR 3) -N (R 2) -A) units in which R 1, R 2, R 3 and A are always identical, and by "heteropolymer", a polymer for which at least one of the units R1, R2, R3 and A is different from the others.

Even more preferably, the polyguanidine derivative used in the composition according to the present invention is chosen from polytetramethyleneguanidinium salts, polyhexamethyleneguanidinium salts, and mixtures thereof, and more particularly halides (fluoride, chloride and bromide), carboxylates. (gluconates, acetates, lactates) or an internal salt ampholyte with a guanidinium group of the chain. Preferably, the derivative used is chosen from polyhexamethyleneguanidinium chloride, polytetramethyleneguanidinium chloride, polytetramethyleneguanidinium acetate and mixtures thereof.

The polyguanidine derivatives that can be used in the context of the present invention can be prepared by implementing any preparation method known from the prior art. In particular, the polyguanidine derivatives according to the present invention may be prepared by mixing an alkylenediamine and a guanidine salt, for example guanidine hydrochloride, in an approximately equimolar ratio, and then heating this mixture to a temperature of between 120.degree. 150 C for a period of between 4 and 10 hours. The mixture of the alkylenediamine and the guanidine salt may be carried out in bulk or in the presence of a solvent, which will preferably be polyethylene glycol (PEG). PEG has the advantage of being a good solvent for the reagents: alkylenediamine and guanidine salt; however, the polyguanidine derivative compound obtained from the reaction is not miscible with PEG. This process therefore makes it possible to directly recover the compound derived from polyguanidine and also to recover the PEG that can be reused as a solvent, as well as the reagents that are in excess or that will not have had time to react.

According to another variant of the process for preparing the polyguanidine derivatives according to the invention, the heating step can be carried out in two stages: a first heating step at a temperature of between 80 and 120 ° C., and preferably about 120 C, for a period between 4 and 5 hours, then a second heating step at a temperature between 120 and 160 C and preferably about 150 C for a period of between 8 and 11 hours.

The process of GEMBITSKII et al., (Zh.Propl.Khen (Leningrad) (1975), 48 (8), 1833-6), as well as the methods described in WO-A-99/54291 and A-439698 may also be used to prepare the polyguanidine derivative compounds used according to the present invention.

The composition according to the invention may contain one or more polyguanidine derivatives. The amount of derivative (s) depolyguanidine (active material) may range, for example from 0.1 to 10% by weight and preferably from 0.2 to 8% by weight relative to the total weight of the composition.

<Desc / Clms Page number 5>

Foaming surfactants The cleaning composition according to the invention constitutes a foaming composition, and it contains at least one foaming surfactant which will bring the foaming character to the composition. This surfactant may be chosen from all nonionic, anionic, amphoteric and zwitterionic foaming surfactants, and mixtures thereof.

 The amount of surfactant (s) weight of active material is greater than 5% by weight. It may range, for example, from 5.1 to 50% by weight, preferably from 6 to 50% by weight, better still from 6 to 30% by weight and even more preferably from 8 to 25% by weight relative to the total weight of the composition.

1. Nonionic surfactants: Nonionic surfactants which may be used include, for example, alkyl polyglucosides (APG), maltose esters, polyglycerolated fatty alcohols, glucamine derivatives such as 2-ethylhexyloxycarbonyl n- methyl glucamine, and mixtures thereof.

As alkylpolyglucosides, use is preferably made of those containing an alkyl group comprising from 6 to 30 carbon atoms and preferably from 8 to 16 carbon atoms, and containing a hydrophilic group (glucoside) preferably comprising 1.2 to 3 units of saccharide. . As alkylpolyglucosides, mention may be made, for example, of decylglucoside (Alkyl-C9 / C11-polyglucoside (1.4)), such as the product marketed under the name MYDOL 10 # by the company Kao Chemicals, under the name PLANTAREN 2000 UP # by the company Cognis, and under the name ORAMIX NS 10 # by the company Seppic, caprylyl / capryl glucoside such as the product sold under the name ORAMIX CG 110 # by the company Seppic, laurylglucoside as the products sold under the names PLANTAREN 1200 N # and PLANTACARE 1200 by the company Cognis; and coco-glucoside, such as the product marketed under the name PLANTACARE 818 / UP® by Cognis.

The maltose derivatives are for example those described in document EP-A-566438, such as O-octanoyl-6'-D-maltose, or else O-dodecanoyl-6'-Dmaltose described in document 2739556.

Among the polyglycerolated fatty alcohols, mention may be made of polyglycerolated dodecanediol (3.5 moles of glycerol), a product manufactured under the name CHIMEXANE NF® by the company Chimex.

2. Anionic Surfactants It is possible to use, for example, as anionic surfactants, carboxylates, alkyl sulphates, oxyethylenated or otherwise, sulphonates, alkyl sulphoacetates, phosphates, polypeptides, anionic derivatives of alkyl polyglucoside, and mixtures thereof.

Examples of carboxylates that may be mentioned include: amido ether carboxylates (AEC), such as sodium lauryl amido ether carboxylate (3 EO) sold under the name AKYPO FOAM 30 by Kao Chemicals;

<Desc / Clms Page number 6>

 polyoxyethylenated carboxylic acid salts, such as the oxyethylenated (6 EO) sodium lauryl ether carboxylate (C12-14-16 65/25/10) sold under the name AKYPO SOFT 45 NV # by the company Kao Chemicals; polyoxyethylenated and carboxymethyl olive oil fatty acids, a product sold under the name OLIVEM 400 # by the company Biologia E Tecnologia; the oxyethylenated (6 EO) sodium tri-decyl ether carboxylate sold under the name NIKKOL ECTD-6NEX by the company Nikkol; acetates, such as the sodium 2- (2-hydroxyalkyloxy) acetate sold under the name BEAULIGHT SHAA by the company Sanyo; the alkaline salts of N-acylamino acids, such as, for example, (1) sarcosinates, such as sodium lauroyl sarcosinate sold under the name SARKOSYL NL 97 # by the company Ciba or under the name ORAMIX L 30 # by the company Seppic; sodium myristoyl sarcosinate, sold under the name NIKKOL SARCOSINATE MN # by the company Nikkol, sodium palmitoyl sarcosinate, sold under the name NIKKOL SARCOSINATE PN # by the company Nikkol; (2) alaninates, such as sodium Nlauroyl-N-methylamidopropionate, sold under the name Sodium Nikkol Alkanate LN 30 # by Nikkol or under the name Alanone Ale® by Kawaken, and N-lauroyl N-methylalanine triethanolamine, marketed under the name ALANONE ALTA by Kawaken; (3) acylglutamates such as triethanolamine monococoylglutamate sold under the name ACYLGLUTAMATE CT-12 by Ajinomoto, and triethanolamine lauroylglutamate marketed under the name ACYLGLUTAMATE LT-12 by the company Ajinomoto; (4) aspartates such as the mixture of triethanolamine N-lauroylaspartate and triethanolamine N-myristoylaspartate, sold under the name ASPARACK by the company Mitsubishi; (5) glycinates, such as sodium N-cocoyl glycinate sold under the names AMILITE GCS-12 and AMILITE GCK 12 by the company Ajinomoto; Citrates such as the citric monoester of oxyethylenated coconut alcohols (9 OA) marketed under the name WITCONOL EC 1129 by the company Goldschmidt; galacturonates, such as the sodium Dodecyl D-galactoside uronate marketed by SOLIANCE; - Soaps which are salts of fatty acids of natural or synthetic origin, salified by a mineral or organic base. The fatty chain may comprise from 6 to 22 carbon atoms, preferably from 8 to 18 carbon atoms. The mineral or organic base may be selected from alkali or alkaline earth metals, amino acids, and amino alcohols. Salts that may be used include, for example, sodium, potassium, magnesium, triethanolamine, N-methylglucamine, lysine and arginine salts. As soap, mention may be made, for example, of potassium or sodium salts of lauric, myristic acids,

<Desc / Clms Page number 7>

 palmitic, stearic (laurate, myristate, palmitate and potassium or sodium stearate), and mixtures thereof.

As oxyethylenated or non-oxyethylated sulphates, mention may be made, for example, of sodium lauryl ether sulphate (C12-14 70/30) (2.2 EO) sold under the name Sipon AOS 225 # by the company Cognis, lauryl ether sulphate and ammonium (C12-14 70/30) (3 EO) sold under the name Sipon LEA 370 # by the company Coqnis, the alkyl (C12-C14) ether (9 EO) ammonium sulphate sold under the name RHODAPEX AB The Rhodium Chimie lauryl and oleyl ether sulphate and magnesium mixture marketed under the name EMPICOL BSD 52 by the company Albright & Wilson.

As sulphonates, mention may be made, for example, of (1) alpha-olefin sulphonates, such as sodium alpha-olefin sulphonate (C14-16) sold under the name BIO-TERGE AS-40 by the names BIO-TERGE AS-40 and denomination BIO-TERGE AS-40 by the company Stepan, under the names WITCONATE AOS PROTEGE and SULFRAMINE AOS PH 12 # by the company Witco, the secondary sodium olefin sulfonate sold under the name HOSTAPUR SAS 30 # by the company Clariant; (2) isethionates such as sodium cocoylisethionate, such as the product sold under the name JORDAPON CI P # by the company Jordan, (3) taurates, such as the sodium salt of palm kernel oil methyltaurate marketed under the name HOSTAPON CT PATE denomination by the company Clariant; N-acyl N-methyltaurates, such as the sodium N-cocoyl N-methyltaurate sold under the name HOSTAPON LT-SF by the company Clariant or marketed under the trademark NIKKOL CMT-30-T by Nikkol, the sodium palmitoyl methyltaurate marketed under the name the name NIKKOL PMT # by the company Nikkol.

As sulfosuccinates, there may be mentioned, for example, the oxyethylenated (3 EO) lauryl alcohol (C12 / C14 70/30) monosulfinate sold under the names SETACIN 103 SPECIAL, REWOPOL SB-FA 30 K 4 # by the company Witco, the di-sodium salt of a hemi-sulfosuccinate of C12-C14 alcohols, sold under the name SETACIN F SPECIAL PASTE by the company Zschimmer Schwarz, the di-sodium oxyethylenated oleamide (2 EO) marketed under the name STANDAPOL SH 135 # by the company Cognis, the oxyethylenated (5 EO) lauric amide mono-sulfosuccinate sold under the name LEBON A-5000 by the company Sanyo.

As phosphates, mention may be made, for example, of monoalkylphosphates and dialkylphosphates, such as lauryl mono-phosphate marketed under the name MAP 20 # by the company Kao Chemicals, the potassium salt of dodecylphosphoric acid, monoblend - and di-ester (majority diester) marketed under the name CRAFOL AP-31 by Cognis, the mixture of monoester and octylphosphoric acid di-ester, sold under the name CRAFOL AP-20 by the company Cognis, the mixture of monoester and ethoxylated 2-butyloctanol phophoric acid diester (7 moles of EO) sold under the name ISOFOL 12 7 EO-PHOSPHATE ESTER® by Condea.

<Desc / Clms Page number 8>

As polypeptides (which are compounds obtained by condensation of a fatty chain on the amino acids of cereals and in particular wheat and oats), there may be mentioned, for example, the potassium salt of lauroyl hydrolysed wheat protein, marketed under the name AMINOFOAM W OR @ by the company Croda; the triethanolamine salt of cocoyl hydrolysed soy protein, sold under the name MAY-TEIN SY # by the company Maybrook; the sodium salt of lauroyl amino acids of oats, sold under the name PROTEOL OAT # by the company Seppic, the collagen hydrolyzate grafted onto the coconut fatty acid, sold under the name GELIDERM 3000 by the company Deutsche Gelatin ; soy proteins acylated with hydrogenated coconut acids, sold under the name PROTEOL VS 22 # by the company Seppic.

As anionic derivatives of alkyl polyglucosides, there may be mentioned in particular citrates, tartrates, sulphosuccinates, carbonates and glycerol ethers obtained from the alkyl polyglucosides. Mention may be made, for example, of the sodium salt of cocoylpolyglucoside (1,4) tartaric ester, sold under the name EUCAROL AGE-ET by the company Cesalpinia; the sodium salt of sulphosuccinic cocoylpolyglucoside ester (1,4), sold under the name Test 512 MP # by the company Seppic; the sodium salt of citric ester of cocoyl polyglucoside (1,4) sold under the name EUCAROL AGE-EC by Cesalpinia, the sodium lauryl polyglucoside ether carboxylate sold under the name PLANTAPON LGC SORB by the company Cognis.

3. Amphoteric and Zwitterionic Surfactants Examples of amphoteric and zwitterionic surfactants that may be used include alkylbetaines, N-alkylamidobetaines and their derivatives, sultaines, alkyl-polyaminocarboxylate (APAC), alkylamphoacetates and mixtures thereof.

As alkyl betaines, mention may be made, for example, of cocobetaine, such as the product sold under the name Dehyton AB-30 by the company Cognis; lauryl betaine, such as the product marketed under the name GENAGEN KB # by Clariant; oxyethylenated laurylbetaine (10 EO), such as the product sold under the name Laurylehert (10 EO) BETAINE by Shin Nihon Rica; oxyethylenated stearylbetaine (10 EO), such as the product marketed under the name Stearyleether (10 EO) BETAINE by the company Shin Nihon Rica.

Among the N-alkylamidobetaines and their derivatives, mention may be made, for example, of cocamidopropyl betaine marketed under the name LEBON 2000 HG® by the company Sanyo, or under the name EMPIGEN BB # by the company Albright &Wilson; lauramidopropyl betaine marketed under the name REWOTERIC AMB12P by the company Witco.

As sultaines, there may be mentioned cocoylamidopropylhydroxy-sulfobetaine marketed under the name CROSULTAINE C-50 by the company Croda.

<Desc / Clms Page number 9>

 As alkyl polyaminocarboxylates (APAC), there may be mentioned sodium cocoylpolyaminocarboxylate, sold under the name AMPHOLAK 7 CX / C, and AMPHOLAK 7 CX # by the company Akzo Nobel; the sodium stearylpolyamidocarboxylate sold under the name AMPHOLAK 7 TX / C® by the company Akzo Nobel; sodium carboxymethylolpropylamine, marketed under the name AMPHOLAK X07 / C @ by the company Akzo Nobel.

As alkylamphoacetates, mention may be made, for example, of N-cocoyl-Ncarboxymethoxyethyl-N-carboxymethyl-ethylenediamine N-di-sodium (CTFA name: disodium cocamphodiacetate), such as the product marketed under the name MIRANOL C2M CONCENTRA NP® by the company Rhodia Chimie; and N-cocoyl-N-hydroxyethyl-N-carboxymethyl-ethylenediamine N-sodium (CTFA name: sodium cocamphoacetate).

According to a preferred embodiment of the invention, the surfactant or surfactants used are chosen from alkylpolyglucosides (APG), alkylbetaines and alkylamidopropylbetaines, phosphates, acylglycinates, alkylsamphoacetates and diacetates, alkyl sulfates and alkyl ether sulfates, and their mixtures.

The aqueous medium of the composition according to the invention may comprise, in addition to water, one or more solvents chosen from lower alcohols containing from 1 to 6 carbon atoms, such as ethanol; polyols, such as, for example, glycerine; glycols such as butylene glycol, isoprene glycol, propylene glycol, polyethylene glycols such as PEG-8; sorbitol; sugars such as glucose, fructose, maltose, lactose, sucrose; and their mixtures. The amount of solvent (s) in the composition of the invention may range, for example, from 0.5 to 50% by weight and preferably from 2 to 30% by weight relative to the total weight of the composition.

The compositions of the invention may comprise adjuvants usually used in the cosmetics field, and in particular those used in cleaning products. As adjuvants, mention may be made, for example, of perfumes, preservatives, sequestering agents (EDTA), pigments, pearlescent agents, mineral or organic fillers, matifying, whitening or exfoliating agents, soluble dyes, cosmetic or dermatological active agents, polymers nonionic such as polyvinylpyrrolidone (PVP), anionic polymers, cationic polymers, fatty substances incompatible with the aqueous medium, such as oils or waxes. The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.01 to 20% of the total weight of the composition. These adjuvants and their concentrations must be such that they do not modify the desired property for the composition of the invention.

Thus, for example, the amount of oils should not be too great, and conveniently any oils present should be in an amount of less than 5% by weight and preferably less than 4% by weight based on the weight total of the composition.

As actives, it is possible to use in the composition of the invention any active ingredient usually used in the cosmetic and dermatological fields, such as, for example, water-soluble or liposoluble vitamins or provitamines such as

<Desc / Clms Page number 10>

 vitamins A (retinol), C (ascorbic acid), B3 or PP (niacinamide), B5 (panthenol), E (tocopherol), K1, beta-carotene, and derivatives of these vitamins and in particular their esters; steroids such as DHEA and 7a-hydroxy DHEA; antiseptics; antiseobrebric and antimicrobial agents such as benzoyl peroxide, salicylic acid, triclosan, tricarban, azelaic acid; moisturizers such as glycerine, hyaluronic acid, pyrrolidone carboxylic acid (PCA) and its salts, sodium pidolate, serine, xylitol, trehalose, ectoin, ceramides, urea; keratolytic and anti-aging agents such as alpha-hydroxy acids such as glycolic acid, citric acid, lactic acid, beta-hydroxy acids such as salicylic acid and its derivatives; enzymes and co-enzymes and especially coenzyme Q10; solar filters; optical brighteners, slimming active agents such as caffeine, theophylline, theobromine, anti-inflammatories such as 18 ss glycyrrhetinic and ursolic acids, and mixtures thereof. A mixture of two or more of these assets can be used. The active agent (s) may for example be present in a concentration ranging from 0.01 to 20%, preferably from 0.1 to 10% and better still from 0.5 to 5% of the total weight of the composition.

As fillers, mention may be made of mineral fillers such as talc or magnesium silicate (particle size: 5 microns) marketed under the name LUZENAC 15 M00 # by the company Luzenac, kaolin or aluminum silicate such as for example that marketed under the name denomination KAOLIN SUPREME by Imerys, or organic fillers such as starch, for example the product marketed under the name Amidon de Mais B # by Roquette, and nylon microspheres sold under the name ORGASOL 2002 UD NAT. COS @ by the company Atochem, the microspheres based on copolymer of vinyl chloride / Acrylonitrile / methacrylon itri enclosing isobutane, expanded such as those sold under the name EXPANCEL 551 DE @ by Expancel. Fibers such as, for example, nylon fibers (Polyamide 0.9 Dtex 0.3MM marketed by the establishments Paul Bonte), cellulose fibers or Rayon can also be added to the composition of the invention (RADIUS FLOCK RCISE N0003 MO4 # marketed by Claremont Flock Corporation).

The foaming compositions according to the invention may be used in the cosmetic and dermatological fields, and they may constitute in particular a cosmetic composition and in particular cleaning or makeup removal products for the skin (body, face, eyes), scalp and / or hair.

They can be used for any type of skin (dry, normal, mixed or oily).

Another subject of the invention consists in the cosmetic use of the cosmetic composition as defined above, as cleaning and / or makeup removal products for the skin, the scalp and / or the hair.

The compositions according to the invention can also be used for the treatment of oily skin, in particular by adding specific active agents for the treatment of oily skin, such as antiseborrhoeic agents such as, for example, acid.

<Desc / Clms Page number 11>

 salicylic acid and its derivatives, azelaic acid, triclosan, tricarban, piroctone olamine, niacinamide (vitamin PP).

Another subject of the invention is the use of the composition as defined above for the preparation of a composition intended for the treatment of oily skin.

Another subject of the invention consists in a cosmetic process for cleaning the skin, including the eyelids and the eyes, the scalp and / or the hair, characterized in that the composition of the invention is applied to the skin, on the scalp and / or on the hair, in the presence of water, and that the foam formed by rinsing with water is eliminated.

The examples which follow serve to illustrate the invention without, however, being limiting in nature. The quantities indicated are in% by weight unless otherwise indicated. The indication M.A. means active ingredient.

In addition, the sensory performances of these examples have been evaluated. Thus, the foam qualities developed by the compositions described below were evaluated according to the protocol described below.

Before any use of the products, the hands are washed with Marseille soap then properly rinsed and dried. Then the protocol followed is as follows:
1- wet hands under running water, shake them three times to wring them out,
2- place 1 g of product in the hollow of one of the hands,
3- work the product between the two palms for 10 seconds,
4- add 2 ml of water and work the product again for 10 seconds,
5- rinse hands under water,
6- wipe them.

Criteria for the quality of the foam are evaluated in step 4. These are the following criteria: - The volume of foam: the score awarded is even higher than the volume is large, and therefore the product is better when the rating is high.

- The size of the bubbles composing the foam: the score awarded is even higher than the bubbles are large, and therefore the product is better when the note is low.

- The density (consistency, holding of the foam): the score is even higher than the density is high, and therefore the product is better when the rating is high.

These criteria are scored on a scale of 0 to 10. The evaluation panel consists of 3 trained experts. The average of the three scores makes it possible to compare the products according to each of the criteria. It is considered that, for a given criterion, there is a difference of note between two compositions when this difference is greater than or equal to 1.

Example 1 according to the invention and Comparative Example 2:

<Desc / Clms Page number 12>

 Table (1) presents these examples.

Comparative Example 2 corresponds to Example 1 according to the invention without polyguanidine derivative.

Table (1)

<Tb>
<tb> Composition <SEP> Example <SEP> 1 <SEP> according to <SEP> Example <SEP> 2
<tb> the invention <SEP> comparative
<tb> Mono-phosphate <SEP> of <SEP> lauryl <SEP> (Mono ester <SEP>: <SEP> 6.5 <SEP> M. <SEP> A. <SEP> 6.5 <SEP> MY
<Tb>

75 <SEP>%) <SEP> (MAP <SEP> 20 <SEP> from <SEP> KAO)
<tb> Decylglucoside <SEP> (MYDOL <SEP> 10 <SEP>) of <SEP> KAO <SEP> to <SEP> 40% <SEP> 6.5 <SEP> M. <SEP> A. <SEP> 6 , 5 <SEP> MA
<Tb>

MY)
<tb> Hydroxide <SEP> of <SEP> potassium <SEP> qs <SEP> pH <SEP> 7 <SEP> 1.7 <SEP> 1.7
<tb> Clhorure <SEP> of <SEP> tetramethylene <SEP> guanidinium <SEP> 5 <SEP> 0
<tb> Demineralized <SEP> water <SEP> Qsp <SEP> Qsp
<tb> 100 <SEP>% <SEP> 100 <SEP>% <SEP>
<tb> Appearance <SEP> Liquid <SEP> viscous <SEP> Liquid
<tb> opalescent <SEP> viscous
<tb> transparent
<Tb>
The sensory results for each of the criteria described above are presented in the following table (2):
Table (2)

<Tb>
<tb> Example <SEP> 1 <SEP> according to <SEP> Example <SEP> 2 <SEP> comparative
<tb> the invention
<tb> Volume <SEP> of <SEP><SEP> Foam <SEP> 7.5 <SEP> 5
<tb> Size <SEP> of <SEP> bubbles <SEP> 5 <SEP> 4,7
<tb> Density <SEP> of <SEP><SEP> Foam <SEP> 7.8 <SEQ> 6.5
<Tb>
The examples described above demonstrate the positive influence of the polyguanidine derivative on the quality of the foam obtained. Example 1 according to the invention gives a more dense and voluminous foam than the comparative example 2, with identical bubble size. It is considered superior to Comparative Example 2.

Example 3 According to the Invention and Comparative Example 4: Table (3) presents these examples.

<Desc / Clms Page number 13>

 Comparative Example 4 corresponds to Example 3 according to the invention without polyguanidine derivative.

Table (3)

<Tb>
<tb> Composition <SEP> Example <SEP> 3 <SEP> according to <SEP> Example <SEP> 4
<tb> the invention <SEP> comparative
<tb> Sodium <SEP> cocoylglycinate <SEP> (Amilite <SEP> GCS-12) <SEP> 6.5 <SEP> MA <SEP> 6.5 <SEP> MA
<Tb>

Cocobetaine <SEP> (Dehyton <SEP> AB30) <SEP> 6.5 <SEP> M. <SEP> A. <SEP> 6.5 <SEP> MA
<Tb>

Hydroxide <SEP> of <SEP> potassium <SEP> qs <SEP> pH <SEP> 7 <SEP> 1.7 <SEP> 1.7
<tb> Clhorure <SEP> of <SEP> tetramethylene <SEP> guanidinium <SEP> 5 <SEP> 0
<tb> Demineralized <SEP> water <SEP> Qsp <SEP> Qsp
<tb> 100 <SEP>% <SEP> 100 <SEP>% <SEP>
<tb> Appearance <SEP> Liquid <SEP> Liquid
<tb> transparent <SEP> transparent
<Tb>
The sensory results for each of the criteria described above are presented in the following table (4):
Table (4)

<Tb>
<tb> Example <SEP> 3 <SEP> according to <SEP> Example <SEP> 4 <SEP> comparative
<tb> the invention
<tb> Volume <SEP> of <SEP> the <SEP> foam <SEP> 8 <SEP> 6.8
<tb> Size <SEP> of <SEP> bubbles <SEP> 5 <SEP> 5.3
<tb> Density <SEP> of <SEP><SEP> Foam <SEP> 8 <SEP> 7.5
<Tb>
The examples described above demonstrate the positive influence of the polyguanidine derivative on the quality of the foam obtained. Example 3 according to the invention gives a denser foam than Comparative Example 4, with identical bubble size and volume. It is considered superior to Comparative Example 4.

Claims (15)

 1. Foaming cleaning composition comprising, in a physiologically acceptable aqueous medium, at least one polyguanidine derivative and one or more foaming surfactants, these surfactants being in an amount greater than 5% by weight relative to the total weight of the composition . 2. Composition according to claim 1, characterized in that it comprises at least 35% by weight of water relative to the total weight of the composition. 3. Composition according to claim 1 or 2, characterized in that the polyguanidine derivative is a compound of formula (I) below:

 in which : X, R 1, R 2 and R 3, independently of one another, are chosen from the group formed by a hydrogen atom, a hydroxyl radical or a linear or branched, saturated or unsaturated C 1 -C 16 alkyl radical; hydroxylated or not, Y denotes an NHR radical, in which R is chosen from the group formed by a hydrogen atom, a hydroxyl radical, a linear or branched, saturated or unsaturated, hydroxylated or non-hydroxylated C1-C16 alkyl radical, A denotes a linear or branched, saturated or unsaturated C 1 -C 16 alkylene radical, substituted or unsubstituted by at least one radical chosen from a hydroxyl, carboxyl or carboxylate radical, a halogen, said alkylene radical possibly containing at least one amine function, ether, thioether, ester, amide, carbamate, urea, a C6-C8 aryl or C3-C8 cyclanic ring optionally substituted with C1-C8 alkyl, hydroxyl, halogen; or A denotes one or more C -C cycloalkyl or C -C cycloalkyl rings optionally substituted with C 1 -C 8 alkyl, hydroxyl or halogen or unsubstituted; or A denotes a C10-C14 polyaryl chain or a C10-C8 polycyclic chain which may be interrupted by at least one C1-C8 alkylene radical, a hydrogen atom, an amine, amide, ether, thioether or carbamate function; urea; n is an integer from 2 to 5000, and its physiologically acceptable salts. 4. Composition according to any one of the preceding claims, characterized in that the polyguanidine derivative is chosen from polytetramethyleneguanidinium salts, polyhexamethyleneguanidinium salts, and mixtures thereof. 5. Composition according to the preceding claim, characterized in that the polyguanidine derivative is chosen from <Desc / Clms Page number 15>  polyhexamethyleneguanidinium, polytetramethyleneguanidinium chloride, polytetramethyleneguanidinium acetate, and mixtures thereof. 6. Composition according to any one of the preceding claims, characterized in that the amount of derivative (s) depolyguanidine ranges from 0.1 to 10% by weight relative to the total weight of the composition. 7. Composition according to any one of the preceding claims, characterized in that the foaming surfactant is chosen from nonionic surfactants, anionic surfactants, amphoteric and zwitterionic surfactants, and mixtures thereof. 8. Composition according to any one of the preceding claims, characterized in that the amount of surfactant (s) ranges from 5.1 to 50% by weight relative to the total weight of the composition. 9. Composition according to any one of the preceding claims, characterized in that the foaming surfactant is chosen from alkylpolyglucosides, maltose esters, polyglycerolated fatty alcohols, glucamine derivatives, carboxylates, oxyethylenated or non-oxyethylated sulphates, sulfonates, alkyl sulphoacetates, phosphates, polypeptides, alkyl polyglucoside anionic derivatives, alkylbetaines, N-alkylamidobetaines and their derivatives, sultaines, alkylpolyaminocarboxylates, alkylamphoacetates, and mixtures thereof. 10. Composition according to the preceding claim, characterized in that the foaming surfactant is chosen from alkylpolyglucosides, alkylbetaines and alkylamidopropylbetaines, phosphates, acylglycinates, alkyls amphoacetates and diacetates, alkyl sulphates and alkyl ether sulphates, and mixtures thereof. . 11. Composition according to any one of the preceding claims, characterized in that it constitutes a cosmetic composition. 12. Cosmetic use of a cosmetic composition according to any one of the preceding claims, as a cleansing and / or cleansing product for the skin, the scalp and / or the hair. 13. Use of the composition according to any one of claims 1 to 10 for the preparation of a composition for the treatment of oily skin. 14. Cosmetic process for cleaning the skin, scalp and / or hair, characterized in that the composition according to any one of Claims 1 to 11 is applied to the skin, to the eyes, to the leather. hair and / or on the hair, in the presence of water, and that the foam formed by rinsing with water is eliminated. Use of at least one polyguanidine derivative for improving the foam quality of a rinse-off foamable cleaning composition comprising, in a physiologically acceptable aqueous medium, one or more surfactants <Desc / Clms Page number 16>  foaming agents in an amount greater than 5% by weight relative to the total weight of the composition.